Rolf Kaiser - Pharma

Author Information

Rolf Kaiser is affiliated with the Institute of Virology at the University of Cologne, located in Cologne, Germany. The information regarding the affiliation was sourced from PubMed, indicating a strong academic and research foundation in virology.

Research Contributions

Rolf Kaiser has made significant contributions to the field of virology, with a focus on HIV and other viral infections. His recent research includes studies on the effectiveness of integrase strand transfer inhibitors in HIV treatment, the detection of HLA-associated mutations, and the characterization of HIV drug resistance. Additionally, he has explored the sensitivity of serological assays for SARS-CoV-2 and the dynamics of respiratory viruses in Central Europe. His work is characterized by a blend of clinical and computational approaches, addressing key issues in viral drug resistance and surveillance.

Aliases

Rolf Kaiser is also known by several aliases, including R Kaiser and R. Kaiser. These variations are commonly used in publications and academic references.

Publication and Citation Metrics

Metric	Value
Total Citation Count	10,786
H-index	54
Total Paper Count	403

Publications:

Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe.

DOI: 10.1111/hiv.13262

Year: 2022

HAMdetector: A Bayesian regression model that integrates information to detect HLA-associated mutations.

DOI: 10.1093/bioinformatics/btac134

Year: 2022

Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters

DOI: 10.3389/fmicb.2022.846943

Year: 2022

Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization

DOI: 10.1016/j.immuni.2021.12.003

Year: 2022

Characterization of HIV‐1 drug resistance among patients with failure of second‐line combined antiretroviral therapy in central Ethiopia

DOI: 10.1111/hiv.13176

Year: 2021

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting

DOI: 10.1007/s10096-021-04169-7

Year: 2021

Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trial

DOI: 10.1016/j.eclinm.2021.101082

Year: 2021

Adapting the geno2pheno[coreceptor] tool to HIV-1 subtype CRF01_AE by phenotypic validation using clinical isolates from South-East Asia.

DOI: 10.1016/j.jcv.2021.104755

Year: 2021

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

DOI: 10.1093/jac/dkab078

Year: 2021

Respiratory Viruses Dynamics and Interactions: Ten Years of Surveillance in Central Europe

DOI: 10.21203/rs.3.rs-957569/v1

Year: 2021

What Roles Do Pharmacists Play in Pharma?

How Can Technology Aid in Management?

What Are Clinical Trials?

What is the Future of ADE Management?

What are the Implications for Pharma Companies?

Why is Regulatory Approval Important?

Who are Pharmacists?

What is Patient Education in Pharma?

What Strategies do Brand-Name Companies Use to Delay Generic Entry?

How Can Cellular Stress Be Measured?

Partnered Content Networks

Relevant Topics